• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据世界卫生组织-国际临床化学联合会第一国际参考物质标准化的147576名瑞典男性和女性的载脂蛋白B和A-I值。

Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials.

作者信息

Jungner I, Marcovina S M, Walldius G, Holme I, Kolar W, Steiner E

机构信息

CALAB Research and CALAB Medical Laboratories, S:t Göran Hospital, Stockholm, Sweden.

出版信息

Clin Chem. 1998 Aug;44(8 Pt 1):1641-9.

PMID:9702950
Abstract

Serum concentrations of apolipoprotein (apo) B and apo A-I were measured from 1985-1996 in a Swedish population sample of 83 112 males and 64 464 females, ages <20 to >80 years, using an automated immunoturbidimetric method calibrated against fresh pools of human serum and commercial calibrators. All values were recalculated in 1997 after calibration against the WHO-IFCC First International Reference Materials. The recalculation factor was 1.059 for apo B, whereas for apo A-I, the correction was: y = 0.989x + 0.101. The total CVs for both apo B and A-I were generally <7%. The mean value (+/- SD) for apo B was 1.31 +/- 0.35 g/L in all males and 1.22 +/- 0.36 g/L in all females. The mean apo A-I concentration was 1.36 +/- 0.22 g/L in males-10% lower than in females (1.51 +/- 0.24 g/L). The mean value of apo B increased up to 60 years of age in males and up to 70 years of age in females. apo A-I concentrations changed only slightly with age in both males and females. apo A-I concentrations among Swedes are nearly identical to those reported recently by two American studies and those obtained in a Finnish population sample. Mean apo B concentrations differ somewhat between the populations but mirror-as expected-differences in total cholesterol concentrations. The highest values were noted in Swedish subjects. The Swedish sample population is, to our knowledge, the largest describing the distribution of apo B and A-I in a general population of adult males and females of all ages determined with procedures standardized and traceable to the WHO-IFCC First International Reference Materials.

摘要

1985年至1996年期间,在瑞典一个年龄范围从不到20岁至80岁以上、包含83112名男性和64464名女性的人群样本中,采用针对新鲜人血清池和商业校准品校准的自动免疫比浊法,测定了血清载脂蛋白(apo)B和apo A-I的浓度。1997年,在使用世界卫生组织-国际临床化学联合会(WHO-IFCC)第一国际参考物质校准后,所有数值都重新进行了计算。apo B的重新计算因子为1.059,而apo A-I的校正公式为:y = 0.989x + 0.101。apo B和apo A-I的总变异系数通常均小于7%。所有男性的apo B平均值(±标准差)为1.31±0.35 g/L,所有女性为1.22±0.36 g/L。男性的apo A-I平均浓度为1.36±0.22 g/L,比女性低10%(女性为1.51±0.24 g/L)。男性的apo B平均值在60岁之前上升,女性在70岁之前上升。男性和女性的apo A-I浓度随年龄变化均较小。瑞典人的apo A-I浓度与最近两项美国研究报告的浓度以及在芬兰人群样本中获得的浓度几乎相同。不同人群之间的apo B平均浓度有所差异,但正如预期的那样,反映了总胆固醇浓度的差异。瑞典受试者的数值最高。据我们所知,瑞典样本人群是描述所有年龄段成年男性和女性总体中apo B和apo A-I分布的最大样本,其测定程序是标准化的且可溯源至WHO-IFCC第一国际参考物质。

相似文献

1
Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials.根据世界卫生组织-国际临床化学联合会第一国际参考物质标准化的147576名瑞典男性和女性的载脂蛋白B和A-I值。
Clin Chem. 1998 Aug;44(8 Pt 1):1641-9.
2
Reference limits of apolipoprotein A-I and apolipoprotein B using an IFCC standardized immunonephelometric method.采用国际临床化学和检验医学联合会(IFCC)标准化免疫比浊法测定载脂蛋白A-I和载脂蛋白B的参考限值。
Eur J Clin Chem Clin Biochem. 1995 Jun;33(6):337-42. doi: 10.1515/cclm.1995.33.6.337.
3
Serum concentrations of apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) in a population sample.
Clin Chem. 1995 Nov;41(11):1633-6.
4
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material.国际临床化学联合会载脂蛋白A-I和B测定标准化项目。III. 使用国际参考物质时载脂蛋白A-I值的可比性。
Clin Chem. 1993 May;39(5):773-81.
5
[Reference values of apolipoproteins A1 and B. Contribution of international standardization. Travail collaboratif entre la SFBC, l'Arcol et le SFRL].[载脂蛋白A1和B的参考值。国际标准化的贡献。法国临床生物学学会、Arcol和法国临床实验室学会之间的合作工作]
Ann Biol Clin (Paris). 1997 Sep-Oct;55(5):451-4.
6
High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study.瑞典男性和女性的高胆固醇及甘油三酯水平:致命性心肌梗死风险增加。AMORIS(载脂蛋白相关死亡风险)研究的首份报告
Blood Press Suppl. 1992;4:35-42.
7
Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females.
Int J Clin Lab Res. 1992;21(3):247-55. doi: 10.1007/BF02591655.
8
Standardization of commercial assays for serum Apo A-I and Apo B: a consensus procedure for the calibration of reference materials.血清载脂蛋白A-I和载脂蛋白B商业检测方法的标准化:参考物质校准的共识程序。
Scand J Clin Lab Invest Suppl. 1990;198:73-9.
9
International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material.国际临床化学联合会载脂蛋白A-I和B测定标准化项目。IV. 使用国际参考物质时载脂蛋白B值的可比性。
Clin Chem. 1994 Apr;40(4):586-92.
10
Apolipoprotein B and AI distributions in the United States, 1988-1991: results of the National Health and Nutrition Examination Survey III (NHANES III).
Clin Chem. 1997 Dec;43(12):2364-78.

引用本文的文献

1
Correlation of serum apolipoprotein B with the Framingham Risk Score among a group of Iraqi subjects: a cross-sectional study.一组伊拉克受试者血清载脂蛋白B与弗雷明汉风险评分的相关性:一项横断面研究。
PeerJ. 2025 Aug 18;13:e19883. doi: 10.7717/peerj.19883. eCollection 2025.
2
Application of IVDr NMR spectroscopy to stratify Parkinson's disease with absolute quantitation of blood serum metabolites and lipoproteins.将体外诊断核磁共振波谱法应用于帕金森病分层,并对血清代谢物和脂蛋白进行绝对定量分析。
Sci Rep. 2025 May 22;15(1):17738. doi: 10.1038/s41598-025-01352-0.
3
Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice.
载脂蛋白 B:弥合证据与临床实践之间的差距。
Circulation. 2024 Jul 2;150(1):62-79. doi: 10.1161/CIRCULATIONAHA.124.068885. Epub 2024 Jul 1.
4
Occupational exposure and health surveys at metal additive manufacturing facilities.金属增材制造设施的职业暴露和健康调查。
Front Public Health. 2023 Nov 20;11:1292420. doi: 10.3389/fpubh.2023.1292420. eCollection 2023.
5
Breastfeeding and ApoB in late adolescence: a Hong Kong birth cohort study.青少年晚期母乳喂养与载脂蛋白 B:一项香港出生队列研究。
Eur J Pediatr. 2023 Aug;182(8):3733-3741. doi: 10.1007/s00431-023-05033-w. Epub 2023 Jun 8.
6
Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS Cohort.成人发病的 1 型糖尿病发病前 20 年相关血糖、脂代谢和炎症的生物标志物的改变:AMORIS 队列研究的结果。
Diabetes Care. 2022 Feb 1;45(2):330-338. doi: 10.2337/dc21-1238.
7
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.载脂蛋白B与心血管疾病:生物标志物及潜在治疗靶点
Metabolites. 2021 Oct 8;11(10):690. doi: 10.3390/metabo11100690.
8
Mass Spectrometry for the Monitoring of Lipoprotein Oxidations by Myeloperoxidase in Cardiovascular Diseases.基于质谱法监测心血管疾病中髓过氧化物酶介导的脂蛋白氧化
Molecules. 2021 Aug 30;26(17):5264. doi: 10.3390/molecules26175264.
9
Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者中载脂蛋白A1与动脉僵硬度之间的性别特异性关联。
PeerJ. 2020 Aug 18;8:e9757. doi: 10.7717/peerj.9757. eCollection 2020.
10
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis.代谢特征预测长期癌症和死亡率:潜在类别分析的应用。
BMC Mol Cell Biol. 2019 Jul 23;20(1):28. doi: 10.1186/s12860-019-0210-7.